These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22898212)

  • 1. Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesterase.
    Liyasova MS; Schopfer LM; Lockridge O
    Chem Biol Interact; 2013 Mar; 203(1):103-7. PubMed ID: 22898212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.
    Carletti E; Schopfer LM; Colletier JP; Froment MT; Nachon F; Weik M; Lockridge O; Masson P
    Chem Res Toxicol; 2011 Jun; 24(6):797-808. PubMed ID: 21438623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cresyl saligenin phosphate, an organophosphorus toxicant, makes covalent adducts with histidine, lysine, and tyrosine residues of human serum albumin.
    Liyasova MS; Schopfer LM; Lockridge O
    Chem Res Toxicol; 2012 Aug; 25(8):1752-61. PubMed ID: 22793878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of diagnostics in the search for an explanation of aerotoxic syndrome.
    Schopfer LM; Furlong CE; Lockridge O
    Anal Biochem; 2010 Sep; 404(1):64-74. PubMed ID: 20447373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS.
    Johnson D; Carter MD; Crow BS; Isenberg SL; Graham LA; Erol HA; Watson CM; Pantazides BG; van der Schans MJ; Langenberg JP; Noort D; Blake TA; Thomas JD; Johnson RC
    J Mass Spectrom; 2015 Apr; 50(4):683-92. PubMed ID: 26149113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry.
    Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M
    Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition kinetics of acetylcholinesterase and butyrylcholinesterase from various species by 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP).
    Horn G; Rappenglück S; Worek F
    Toxicol Lett; 2024 May; 396():28-33. PubMed ID: 38642675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cresyl phosphate-modified butyrylcholinesterase in human plasma for chemical exposure associated with aerotoxic syndrome.
    Schopfer LM; Masson P; Lamourette P; Simon S; Lockridge O
    Anal Biochem; 2014 Sep; 461():17-26. PubMed ID: 24892986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase.
    Jiang W; Murashko EA; Dubrovskii YA; Podolskaya EP; Babakov VN; Mikler J; Nachon F; Masson P; Schopfer LM; Lockridge O
    Anal Biochem; 2013 Aug; 439(2):132-41. PubMed ID: 23624322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to tri-o-cresyl phosphate detected in jet airplane passengers.
    Liyasova M; Li B; Schopfer LM; Nachon F; Masson P; Furlong CE; Lockridge O
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):337-47. PubMed ID: 21723309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthy F-16 pilots show no evidence of exposure to tri-ortho-cresyl phosphate through the on-board oxygen generating system.
    Tacal O; Schopfer LM
    Chem Biol Interact; 2014 May; 215():69-74. PubMed ID: 24661946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying safer anti-wear triaryl phosphate additives for jet engine lubricants.
    Baker PE; Cole TB; Cartwright M; Suzuki SM; Thummel KE; Lin YS; Co AL; Rettie AE; Kim JH; Furlong CE
    Chem Biol Interact; 2013 Mar; 203(1):257-64. PubMed ID: 23085349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of neurotoxic effects of tri-cresyl phosphates (TCPs) and cresyl saligenin phosphate (CBDP) using a combination of in vitro techniques.
    Hausherr V; Schöbel N; Liebing J; van Thriel C
    Neurotoxicology; 2017 Mar; 59():210-221. PubMed ID: 27288108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of organophosphorus (OP) exposures in humans.
    Marsillach J; Richter RJ; Kim JH; Stevens RC; MacCoss MJ; Tomazela D; Suzuki SM; Schopfer LM; Lockridge O; Furlong CE
    Neurotoxicology; 2011 Oct; 32(5):656-60. PubMed ID: 21767566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers.
    Doorn JA; Schall M; Gage DA; Talley TT; Thompson CM; Richardson RJ
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):73-80. PubMed ID: 11601883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies.
    Masson P; Lushchekina S; Schopfer LM; Lockridge O
    Biochem J; 2013 Sep; 454(3):387-99. PubMed ID: 23782236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.
    Gilley C; MacDonald M; Nachon F; Schopfer LM; Zhang J; Cashman JR; Lockridge O
    Chem Res Toxicol; 2009 Oct; 22(10):1680-8. PubMed ID: 19715348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
    Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
    Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detectable organophosphorus pesticide exposure in the blood of Nebraska and Iowa residents measured by mass spectrometry of butyrylcholinesterase adducts.
    Jiang W; Lockridge O
    Chem Biol Interact; 2013 Mar; 203(1):91-5. PubMed ID: 22989774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly observed spontaneous activation of ethephon as a butyrylcholinesterase inhibitor.
    Liyasova MS; Schopfer LM; Kodani S; Lantz SR; Casida JE; Lockridge O
    Chem Res Toxicol; 2013 Mar; 26(3):422-31. PubMed ID: 23410221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.